financetom
Business
financetom
/
Business
/
Update: Boralex Outlines Targets For 2030
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Update: Boralex Outlines Targets For 2030
Jun 17, 2025 8:53 AM

11:43 AM EDT, 06/17/2025 (MT Newswires) -- (Adds comment and updates shares.)

Boralex ( BRLXF ) said Tuesday it plans to achieve compound annual operating income growth of 12% to 14% though 2030 as the company outlined its strategic plan and financial objectives.

As it staged its annual investor day, the renewable-power producer also said it aims to achieve consolidated EBITDA growth of 7% to 9% and combined EBITDA of 8%-10%. It flagged cash-flow growth related to operating activities per share and of discretionary cash flows per share between 8% to 10%.

On its main business indicators, Boralex ( BRLXF ) plans total investments of $6.8 billion, plus $1.2 billion for projects scheduled to be commissioned after 2030. It sees minimum levered internal rate of return on investments threshold of between 10% and 12% adjusted for specific risks by region and technology as well as changes in cost of capital. It also sees payout ratio of 20% to 40% in discretionary cash flows.

Among strategy highlights, Boralex ( BRLXF ) cited an increase in the weighted average remaining contract duration from 11 years in 2024 to 14 years by 2030, and doubling the company's installed capacity every five years within an environment aimed at a net-zero trajectory by 2050.

"In a context where climate risk remains one of the main business risks globally, our strategy aims to combine sustainable growth with performance through the production of renewable and affordable energy," chief executive Patrick Decostre said.

"By executing this plan, we are unlocking the full potential of our business model, which will allow us to seize the most promising opportunities in the four markets where we are already active and where demand for renewable energy is growing rapidly," Decostre added.

National Bank of Canada maintained its outperform rating and $42,00 price target on the company's shares following the outlook.

The bank said it expects the market to positively view Boralex's ( BRLXF ) introduction of cash flow per share metrics and overarching plan. But it noted that the overhang regarding U.S. Senate progress on wind and solar tax credits may offset sentiment.

Boralex ( BRLXF ) shares were last seen up $0.37 to $33.10 on the Toronto Stock Exchange.

Price: 33.06, Change: +0.33, Percent Change: +1.01

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Kanzhun's Board Approves New $150 Million Share Repurchase Program
Kanzhun's Board Approves New $150 Million Share Repurchase Program
Aug 29, 2024
08:09 AM EDT, 08/29/2024 (MT Newswires) -- Kanzhun ( BZ ) said Thursday that the company's board of directors has authorized a new $150 million share repurchase program, starting Aug. 29 for 12 months. The new program will operate together with the existing $200 million share repurchase program that became effective on Mar. 20 for 12 months, the company said....
Umb Financial Insider Sold Shares Worth $735,162, According to a Recent SEC Filing
Umb Financial Insider Sold Shares Worth $735,162, According to a Recent SEC Filing
Aug 29, 2024
04:14 PM EDT, 08/27/2024 (MT Newswires) -- James D Rine, President, on Aug. 23, sold 7,315 shares in Umb Financial ( UMBF ) for $735,162. Following the Form 4 filing with the SEC, Rine has control over a total of 46,339 shares of the company, with 44,917 shares held directly and 1,422 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/101382/000112760224022963/xslF345X05/form4.xml ...
Catalent Fiscal Q4 Adjusted Earnings, Net Revenue Climb
Catalent Fiscal Q4 Adjusted Earnings, Net Revenue Climb
Aug 29, 2024
08:08 AM EDT, 08/29/2024 (MT Newswires) -- Catalent ( CTLT ) reported fiscal Q4 adjusted earnings Thursday of $0.65 per diluted share, up from $0.02 a year earlier. Analysts polled by Capital IQ expected $0.56. Net revenue for the quarter ended June 30 was $1.3 billion, up from $1.06 billion a year earlier. Analysts polled by Capital IQ expected $1.24...
XORTX Surges 62% in U.S. Premarket as Peer-Reviewed Research Backs Company's Approach to Polycystic Kidney Disease
XORTX Surges 62% in U.S. Premarket as Peer-Reviewed Research Backs Company's Approach to Polycystic Kidney Disease
Aug 29, 2024
08:09 AM EDT, 08/29/2024 (MT Newswires) -- XORTX Therapeutics ( XRTX ) jumped 62% on Thursday in New York premarket trading after the company said that recent peer-reviewed, independent, published research shows genetic factors are linked to the over-expression of xanthine oxidase (XO) and play a role in several diseases, including kidney disease. The findings support the company's approach to...
Copyright 2023-2026 - www.financetom.com All Rights Reserved